Clinical Trials
296 trialsGLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
University of Arizona
Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
Novartis
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients
Stanford University
CoSMMO
University of Colorado, Denver
AI-Integrated Emotional Granularity Training for Resilience and Quality of Life in Colorectal Cancer Survivors
The Hong Kong Polytechnic University
AI-empowered Nudge to Improve Colonoscopy Uptake (AINC)
Fudan University
Optimising Colorectal Cancer Patient Pathways
University of Edinburgh
A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance
Jiangsu Cancer Institute & Hospital
A Study of Fruquintinib in Adults With Metastatic Colorectal Cancer in Poland
Takeda
A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors
Huahui Health
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
GV20 Therapeutics
Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
Transversus Abdominis Plane and Rectus Sheath Block for Robotic Colectomy
Tri-Service General Hospital
FECCO-BioBank
University Hospital, Montpellier
Guardant Shield Colorectal Cancer Screening
University of Miami
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
Exelixis
FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)
Sun Yat-sen University
HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization
Mayo Clinic
PACHA-02
UNICANCER
The Canopy Cancer Collective Clinical Registry Protocol
Canopy Cancer Collective, LLC
CARE II
Neptune Medical
NUTRICOLOR
Istituto Clinico Humanitas
Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers
Xijing Hospital
COLIBRI-GI
UNICANCER
Comparing Efficacy and Safety of Enlituo® Versus Erbitux® Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status.
Taizhou Mabtech Pharmaceutical Co.,Ltd
A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
Beijing DCTY Biotech Co.,Ltd.
IGNITE-CRC
National Cancer Center Hospital East
TCR1188-ABC Cells in KRAS-mutated Cancers
University of Pennsylvania
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
National Cancer Institute (NCI)
Transcutaneous Electrical Acustimulation on Postoperative Bowel Function Recovery in Elderly Patients
Sir Run Run Shaw Hospital
A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33
SmartNuclide Biopharma
Histidine and Immunotherapy Response in Colorectal Cancer
Shanghai Jiao Tong University School of Medicine
ODI-2001-01
Centre Georges Francois Leclerc
A Prospective Study of a Subharmonic-Aided Pressure Estimate Technology for Early Prediction of Response to Systemic Therapy in Colorectal Cancer Liver Metastases
The First Hospital of Jilin University
CRIS
University Hospital, Ghent
A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer
Hebei Medical University Fourth Hospital
A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
A Phase I Trial of S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas
Cedars-Sinai Medical Center
AIC-DC
University of Oklahoma
Effects of Berberine on the Human Gut Microbiome
Shanghai Jiao Tong University School of Medicine
Histidine Supplementation for Antitumor Immunity in Colorectal Cancer
Shanghai Jiao Tong University School of Medicine
Secondary Care Colorectal Cancer Pathway Review
University of Edinburgh
PREDIPER
Assistance Publique - Hôpitaux de Paris
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
Fred Hutchinson Cancer Center
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Cedars-Sinai Medical Center
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases
Tianjin Medical University Cancer Institute and Hospital
A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors
Philogen S.p.A.